Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases Posted on January 22, 2025 This week, the FDA expanded the approval of Johnson & Johnson’s ketamine-based nasal spray, Spravato.
How PAM Mitigates Insider Threats: Preventing Data Breaches, Privilege Misuse, and More News When people think of cybersecurity threats, they often picture external… rooter March 26, 2025 1 min read 0
CrowdStrike Reveals Root Cause of Global System Outages News Cybersecurity company CrowdStrike has published its root cause analysis detailing… rooter August 7, 2024 1 min read 0
Pervasive LLM Hallucinations Expand Code Developer Attack Surface News The tendency of popular AI-based tools to recommend nonexistent code… rooter April 4, 2024 1 min read 0
New Ransomware Group Exploiting Veeam Backup Software Vulnerability News A now-patched security flaw in Veeam Backup & Replication software… rooter July 10, 2024 1 min read 0